Group Faults the F.D.A. on Oversight of Devices
By BARRY MEIER
The Government Accountability Office found that the F.D.A. is continuing to approve dozens of high-risk medical devices annually with little review.
The Government Accountability Office found that the F.D.A. is continuing to approve dozens of high-risk medical devices annually with little review.
The multibillion-dollar market is being driven by novel applications to compete with coming generics.
The two largest studies of Alzheimer’s disease led to the discovery of five genes that provide intriguing new clues to why it strikes and how it progresses.
Older men are getting screened for prostate cancer at a higher rate, though many experts discourage screening for men whose life expectancy is 10 years or less.
People with elevated blood sugar who took pioglitazone, sold as Actos, reduced their risk of developing diabetes by 72 percent, researchers report.
Colorful ceramics for sale across the country might contain enough lead to cause health problems when diners use them, researchers found.
People who are distracted during a meal eat more, and are hungrier afterward, than those who concentrate on just eating.
Medical groups are working hard to make patients more aware of distracted driving and its high toll.
A wave of emerging research suggests that seasonal allergies can be psychologically harmful.
In the news: Estrogen, Mormons and Alzheimer’s. Test your knowledge of this week’s health news.
A genetic disease that causes weakness in the hands, arms, feet and legs, C.M.T. can cause difficulty walking and performing tasks.
New York Times science reporter Gina Kolata responds to reader questions about Alzheimer’s disease.
Track the variability of cost in the Medicare system and the rates of several kinds of surgery.
The latest news and scientific perspective on common diseases and conditions.